TriSalus Life Sciences Inc. (TLSI)
US$ 5.731.42%
Price Chart
Key Statistics
Market Cap
$ 161.02M
P/E Ratio
0.00
Revenue (TTM)
$ 32.14M
Volume
19.51K
52W High
$ 6.04
52W Low
$ 3.50
Dividend Yield
0.00%
Beta
0.50
Technicals
50-Day MA
5.0652
200-Day MA
4.9592
52 Week High
6.04
52 Week Low
3.5
About TLSI
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with dif.
Employees
110
Headquarters
Westminster, CO
CEO
Ms. Mary T. Szela B.S.N., M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg